(Updated - June 21, 2022 10:56 AM EDT)BofA Securities analyst Joanna Gajuk downgraded Amedisys (NASDAQ: AMED) from Neutral to Underperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE